COMPOSITIONS AND METHODS FOR TREHALOSE PHOSPHOLIPIDS

IN OVO VACCINE COMPOSITIONS AGAINST COCCIDIOSIS

OIL-BASED ADJUVANTS

Nucleoside-modified RNA for Inducing an Adaptive Immune Response

USE OF TRIMANGANESE TETRAOXIDE PARTICLES IN PREPARATION OF VACCINE ADJUVANT

EXPRESSION OF EIMERIA SEQUENCES IN PLANTS AND PLANT PRODUCED VACCINE FOR SAME

Novel Adjuvant Compositions

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS

IMMUNOGENIC COMPOSITION

Vaccine Compositions for Trypanosomatids

Antigens for detecting toxoplasma infection by monitoring cellular immunity

Oil-based adjuvants

Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases

Compositions and methods of enhancing immune responses

Attenuated strain and vaccine

CRYPTOSPORIDIOSIS VACCINE

Compositions and methods of enhancing immune responses to or limiting infection

Immunologically active fragments of toxoplasma gondii

Compositions and methods of enhancing immune responses

ANTIGENS FOR DETECTING TOXOPLASMA INFECTION BY MONITORING CELLULAR IMMUNITY

Compositions and methods for regulation of chronic toxoplasma infection

Nucleoside-modified RNA for inducing an adaptive immune response

Toxoplasma gondii vaccines and their use

NOVEL COMPOSITIONS AND METHODS FOR TREHALOSE PHOSPHOLIPIDS

SERUM FREE INTRACELLULAR PATHOGEN VACCINE

Nucleoside-Modified RNA For Inducing an Adaptive Immune Response

Vaccine used for preventing toxoplasma gondii infection and preparation method therefor

Adjuvant compositions

COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY

Anti-parasitic immunological compositions

Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

Gel delivery system for treating poultry

Parasite vaccine

Oil-based adjuvants

NEW ATTENUATED STRAINS OF APICOMPLEXA AND THEIR USE AS ANTIGEN VECTORS FOR THE PREVENTION OF INFECTIOUS DISEASES

SYSTEMS AND METHODS OF PREPARING AND DELIVERING OOCYST SOLUTIONS

vaccine

ARTIFICIAL ANTIGEN PRESENTING CELLS HAVING A DEFINED AND DYNAMIC SHAPE

Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

TOXOPLASMA GONDII VACCINES AND THEIR USE

COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY

LIPOSOMAL METHODS FOR PURIFICATION OF PROTEINS

Compositions and methods of enhancing immune responses to or limiting infection

Immune modulator and vaccine composition containing the same

TOXOPLASMA GONDII VACCINES AND THEIR USE

Antigens for detecting toxoplasma infection by monitoring cellular immunity

Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same

Vaccine comprising drug and parasite administration

Gel for treating infectious bronchitis

Oil-based adjuvants

Adjuvant compositions

Method of reducing reactogenicity induced by administration of vaccine or immunogenic composition

Compositions and methods of enhancing immune responses to

vaccine composition

IMMUNOASSEMBLIN (IA) PROTEIN COMPLEXES

Nucleoside-Modified RNA For Inducing an Adaptive Immune Response

Transfection vector for pathogenic amoebae and uses thereof

ANTIBIOTIC-FREE COMPOSITIONS FOR THE PREVENTION OR CONTROL OF COCCIDIOSIS

Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections

Soft gel delivery method for treating poultry

Compositions and methods of enhancing immune responses to or limiting infection

Production and application of protozoa cultures of Histomonas meleagridis (H. meleagridis)

Liposomal adjuvant compositions

Adjuvant compositions

Multicomponent or monocomponent vaccine to be used against chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure

Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same

In vivo induced toxoplasma gondii protein for application in diagnosis, vaccine and therapy

RECOMBINANT BACTERIUM AND METHODS OF ANTIGEN AND NUCLEIC ACID DELIVERY

Compositions and methods of enhancing immune responses to or limiting infection

Soft gel delivery system for treating poultry

Methods for freeze-drying and rehydrating biologics

Adjuvanted vaccines for in ovo avian vaccination

Vaccine

Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan

IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR TREATING DISEASE WITH MODIFIED HOST DEFENSE PEPTIDES

Vaccines against apicomplexan pathogens

Method for treating pancreatic cancer with vaccine

Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections

USE OF ATTENUATED PARASITE STRAINS FOR THE PREVENTION AND/OR TREATMENT OF EYE WOUNDS ASSOCIATED WITH AN INFECTION BY TOXOPLASMA GONDII

Mucosal membrane receptor and uses thereof

Compositions and methods of enhancing immune responses to or limiting infection

Compounds and methods for targeted immune system delivery

Pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent

Compositions and methods of enhancing immune responses to Eimeria

Synthesis of diverse glycosylphosphatidylinositol glycans from and their application as vaccines and diagnostics

Mutant strains of and uses thereof

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

USE OF ATTENUATED STRAINS OF PARASITES FOR THE PREVENTION OR TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN APICOMPLEXAN

Production and application of protozoa cultures of ()

Oil-based adjuvants

28 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 response

Modified coiled coil type proteins having improved properties

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

Artificial antigen presenting cells having a defined and dynamic shape

Use of the PACAP as a molecular adjuvant for vaccines

Use of a food additive based on at least one phytonutrient for stimulating vaccine immunity against apicomplexa in animals

Adjuvant incorporation in immunoanotherapeutics

PLANT PRODUCED VACCINE FOR AMEBIASIS

Adjuvant compositions

METHODS AND COMPOSITIONS FOR INDUCING A T-CELL RESPONSE TO PLASMODIUM SPECIES

USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS

Vaccines against

Anti-malaria compositions and methods

Vaccine Composition

Adjuvant incorporation in immunonanotherapeutics

Survivin-derived peptides and uses thereof

Parasite vaccine

Gel vaccine delivery system for treating poultry

COMPOSITION

Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof

AUXOTROPHIC RECOMBINANT BCG STRAIN PASTEUR AND USE THEREOF IN THE CONTROL OF HUMAN INFECTIONS CAUSED BY PARASITES

Recombinant bacterium and methods of antigen and nucleic acid delivery

Method for treating cancer with vaccine

Immunogenic compositions and uses thereof

Adjuvant incorporation in immunonanotherapeutics

Vaccination against malignant melanoma using bcg and/or vaccinia

Soft gel delivery system for treating poultry

DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same

USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS

HELMINTH ANTIGEN AND IMMUNOTHERAPY

Mucosal membrane receptor and uses thereof

Compositions and methods of enhancing immune responses to

Parasite vaccine

CHIMERIC RECOMBINANT ANTIGENS OF TOXOPLASMA GONDII

VACCINE TARGETS AND DELIVERY SYSTEMS FOR CRYPTOSPORIDIUM

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

Vaccination with killed but metabolically active (KBMA) protozoans with toll-like receptor agonists

Multicomponent or monocomponent vaccine to be used against Chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure

Plant Produced Vaccine for Amebiasis

Adjuvancy and immune potentiating properties of natural products of

USE OF A NEW ISOLATE OF NEOSPORA CANINUM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND FOR PREPARATION OF PRODUCTS FOR TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY NEOSPORA

Immunomodulatory compositions and methods for treating disease with modified host defense peptides

vaccines and uses thereof

Adjuvant incorporation in immunonanotherapeutics

Digalactolipidic Antigen Exposed on the Surface of Apicomplex Parasites, and Diagnostic and Therapeutic Use Thereof

Adjuvant compositions

Immunogenic compositions and uses thereof

Construction of Recombinant Adenovirus With Genes That Codify for SAG1, SAG2 and SAG3

vaccine

Adjuvancy and immune potentiating properties of natural products of

Vaccine composition and uses thereof

Chimeric recombinant antigens of

PLANT PRODUCED VACCINE FOR AMEBIASIS

Pharmaceutical compositions containing 1-methyl-D-tryptophan

AMEBIASIS VACCINE

Plant Produced Vaccine for Amebiasis

EXPRESSION OF AN ANTIMICROBIAL PEPTIDE VIA THE PLASTID GENOME TO CONTROL PHYTOPATHOGENIC BACTERIA

Chimeric recombinant antigens of

Parasite vaccine

Nucleic acids encoding antigen and uses thereof

Soft gel delivery system for treating poultry

Protozoan strains of reduced virulence and use thereof

Survivin-derived peptides and use thereof

Equine protozoal myeloencephalitis vaccine

Recombinant Vaccine Against Fish Infectious Diseases

Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen

Packaged virus-like particles

Lipoglycan compositions and methods of treating parasitic infections

Nucleic acids encoding antigen and uses thereof

Protozoan derived compositions and methods of use thereof

Live genetically engineered protozoan vaccine

Attenuated live Neospora vaccine

Adjuvancy and immune potentiating properties of natural products of

Toxoplasma gondii apical membrane antigen-1

vaccines

Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components

Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen

Compositions and methods for immunotherapy of human immunodeficiency virus (HIV)

Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases

Inducing cellular immune responses to using peptide and nucleic acid compositions